IQVIA HOLDINGS INC.

(IQV)
  Report
Delayed Nyse  -  05/16 03:47:36 pm EDT
206.29 USD   -1.16%
05/05TikoMed AB and IQVIA Announce Strategic Collaboration for the Development of TikoMed's Lead Drug Platform Candidate ILB®
CI
05/04TRANSCRIPT : IQVIA Holdings Inc. - Special Call
CI
04/29IQVIA Holdings Shares Rise Midday Following Piper Upgrade, Target Increase
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

IQVIA HOLDINGS INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

01/27/2022 | 06:03am EDT

Item 5.02 Departure of Directors or Certain Officers; Election of Directors;

Appointment of Certain Officers; Compensatory Arrangements of Certain

Officers

The Board of Directors (the "Board") of IQVIA Holdings Inc. (the "Company") appointed Leslie Wims Morris and Sheila A. Stamps to the Board on January 24, 2022 and January 26, 2022, respectively. Ms. Wims Morris will serve as a Class III director, and Ms. Stamps will serve as a Class I director. The Board determined that each of Ms. Wims Morris and Ms. Stamps satisfies the New York Stock Exchange definition of "independent director."

In connection with their respective appointments to the Board, Ms. Wims Morris and Ms. Stamps are both expected to enter into the Company's standard indemnification agreement with non-management directors, a copy of which is filed as Exhibit 10.8 to the Company's Current Report on Form 8-K filed on October 3, 2016 and is incorporated herein by reference. Each of Ms. Wims Morris and Ms. Stamps will participate in the non-employee director compensation arrangements established by the Company for non-employee directors, as described under "Director Compensation" in the Company's proxy statement dated February 26, 2021 for its 2021 annual meeting of stockholders.

Item 7.01. Regulation FD Disclosure

The Company issued press releases announcing the appointment of each of Ms. Wims Morris and Ms. Stamps, which are attached hereto as Exhibit 99.1 and Exhibit 99.2, respectively, and are incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits




Exhibit
  No.       Description

99.1          Press release dated January 24, 2022

99.2          Press release dated January 26, 2022

104         Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about IQVIA HOLDINGS INC.
05/05TikoMed AB and IQVIA Announce Strategic Collaboration for the Development of TikoMed's ..
CI
05/04TRANSCRIPT : IQVIA Holdings Inc. - Special Call
CI
04/29IQVIA Holdings Shares Rise Midday Following Piper Upgrade, Target Increase
MT
04/29Piper Sandler Lifts IQVIA Holdings to Overweight From Neutral, Price Target to $255 Fro..
MT
04/28IQVIA HOLDINGS INC. Management's Discussion and Analysis of Financial Condition and Re..
AQ
04/28Tranche Update on IQVIA Holdings Inc.'s Equity Buyback Plan announced on October 31, 20..
CI
04/28Stifel Nicolaus Adjusts Price Target for IQVIA Holdings to $271 From $297, Maintains Bu..
MT
04/28KeyBanc Adjusts IQVIA Holdings' Price Target to $250 from $290, Keeps Overweight Rating
MT
04/28IQVIA HOLDINGS INC. : SEC Filing 10Q-1
CO
04/27SECTOR UPDATE : Health Care Stocks Edge Higher Pre-Bell Wednesday
MT
More news
Analyst Recommendations on IQVIA HOLDINGS INC.
More recommendations